Inspira Technologies (NASDAQ:IINN), a pioneer in medical technology, announced today that it has received its first purchase order from Glo-Med Networks for five units of its INSPIRA™ ART100 systems.
These units are slated for shipment in the fourth quarter of 2024.
Additionally, the agreement includes an option for Glo-Med to purchase up to 20 more systems, pending further negotiations.
This initial order and the potential future purchases represent a significant milestone in Inspira’s growth strategy.
The company is currently developing the INSPIRA™ ART (Gen 2), which targets the $19 billion mechanical ventilator market.
This next-generation technology aims to offer an alternative to traditional mechanical ventilation.